ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.

Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, Salvador H, Azizi AA, Mautner V, Röhl C, Peltonen S, Stivaros S, Legius E, Oostenbrink R, ERN GENTURIS NF1 Tumour Management Guideline Group

Open source

DOI: 10.1016/j.eclinm.2022.101818
Published: 2023 Feb
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2022.101818,
  title = {ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.},
  author = {Carton C and Evans DG and Blanco I and Friedrich RE and Ferner RE and Farschtschi S and Salvador H and Azizi AA and Mautner V and Röhl C and Peltonen S and Stivaros S and Legius E and Oostenbrink R and ERN GENTURIS NF1 Tumour Management Guideline Group},
  year = {2023},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2022.101818},
  url = {https://doi.org/10.1016/j.eclinm.2022.101818}
}

RIS

TY  - JOUR
TI  - ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.
AU  - Carton C
AU  - Evans DG
AU  - Blanco I
AU  - Friedrich RE
AU  - Ferner RE
AU  - Farschtschi S
AU  - Salvador H
AU  - Azizi AA
AU  - Mautner V
AU  - Röhl C
AU  - Peltonen S
AU  - Stivaros S
AU  - Legius E
AU  - Oostenbrink R
AU  - ERN GENTURIS NF1 Tumour Management Guideline Group
PY  - 2023
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2022.101818
UR  - https://doi.org/10.1016/j.eclinm.2022.101818
ER  -

APA

C, C., DG, E., I, B., RE, F., RE, F., S, F., H, S., AA, A., V, M., C, R., S, P., S, S., E, L., R, O., & Group, E. G. N. T. M. G. (2023). ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101818

Source records

pubmed · retrieved 2026-09-26T05:26:34.920Z